Prognostic variables in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy
- 1 May 1996
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 26 (5) , 305-317
- https://doi.org/10.1002/(sici)1096-911x(199605)26:5<305::aid-mpo2>3.0.co;2-m
Abstract
Possible prognostic variables for tumor response, time to progression (TTP), and survival in 141 patients with advanced colorectal cancer treated with fluorouracil and leucovorin‐based chemotherapy were analyzed. None of the variables examined for their possible influence on tumor response attained significance in the stepwise logistic regression. In the univariate analysis, variables found to be strongly associated with TTP were performance status (PS) (P = 0.0301), liver involvement (P = 0.030), and the initial values of WBC (P = 0.0319), lactic dehydrogenase (LDH; P = 0.0053), γ‐glutamyl‐transpeptidase (γ‐GT; P = 0.0013), alkaline phosphatase (ALP; P = 0.0186), albumin (P = 0.0004), and carcinoembryonic antigen (CEA; P = 0.0014). In the Cox analysis, liver involvement (P = 0.0553), albumin (P = 0.0181), PS (P = 0.0484), and ALP (P = 0.0553) were retained as independently significant variables. When only patients with liver metastases were included in the analysis, then only albumin (P < 0.001) demonstrated a prognostic significance. Also, in the univariate analysis, variables predicting survival were PS (P = 0.0230), grade (P = 0.0060), liver involvement (P = 0.0002), LDH (P = 0.0001), γ‐GT (P < 0.001), ALP (P = 0.0006), albumin (P = 0.0309), and CEA (P = 0.0005). With the multivariate analysis, γ‐GT (P = 0.004), albumin (P = 0.0634), and CEA (P = 0.0804) were selected as significant. In those patients who presented with liver involvement, variables predicted survival were γ‐GT (P = 0.0041), albumin (P = 0.0442), and the percentage of involved liver parenchyma (P = 0.0690). These results could be helpful for the stratification of future trials in advanced colorectal cancer.Keywords
This publication has 41 references indexed in Scilit:
- What can we learn from a meta-analysis of trials testing the modulation of 5-FU by leucovorin?Annals of Oncology, 1993
- Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinomaEuropean Journal Of Cancer, 1992
- Original article: Fluorouracil-alone versus high-dose folinic acid and fluorouracil in advanced colorectal cancer: A randomized trial of the Italian Oncology Group for Clinical Research (GOIRC)Annals of Oncology, 1992
- Clinical and pathologic prognostic indicators in colorectal cancer. A population‐based studyCancer, 1992
- Fluorouracil als Monotherapie oder in Kombination mit Folinsäure in der Behandlung des metastasierten kolorektalen KarzinomsDeutsche Medizinische Wochenschrift (1946), 1992
- Folinic acid + 5-Fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of ‘GISCAD’ (Italian Group for the Study of Digestive Tract Cancer)Annals of Oncology, 1991
- Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.Journal of Clinical Oncology, 1989
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- Testing Goodness of Fit of Cox's Regression and Life ModelPublished by JSTOR ,1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958